Skip to main content
OpenTrials
Completed

NCT Number: NCT02318823

Effects of Beer (Alcohol) on Social Cognition

The present study aims to evaluate effects of beer (alcohol) on social cognition.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

18 year–50 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University Hospital Basel

Basel, Switzerland

About this study

Alcohol is one of the most widely used recreational drugs and it is often used in social settings to enhance sociability. There are few data showing that acute alcohol consumption affects facial emotion recognition. However the acute effects of alcohol in social drinkers on different aspects of social cognition are largely unknown. In the present study, we will therefore evaluate effects of beer (alcohol) on social cognition. The study will include 60 subjects (30 male, 30 female) and use a placebo-controlled, crossover design with the two experimental conditions alcoholic beer (individually calculated amount aiming to achieve a blood-alcohol concentration of 0.4g/kg), and non-alcoholic beer (placebo). We primarily aim to evaluate whether beer (alcohol) affects the ability to correctly decode emotions in facial expressions using different facial emotion recognition Tasks. Additionally, appraisal of visual erotic stimuli following alcohol consumption will be evaluated. Subjective social and mood effects will be assessed using validated questionnaires. Blood samples will be collected to assess plasma levels of the "social hormone" oxytocin as well as blood alcohol levels to test possible associations with effects on emotional processing.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age between 18 and 50 years
  • Sufficient understanding of the German language
  • Subjects understand the procedures and the risks associated with the study
  • Participants must be willing to adhere to the protocol and sign the consent form
  • Participants must be willing to refrain from drinking alcohol in the evening preceding the study session
  • Participants must be willing to abstain from excessive drinking and from taking illicit psychoactive drugs during the study.
  • Participants must be willing not to eat or drink xanthine-containing liquids (such as coffee, black or green tea, red bull, chocolate) 3 h prior to the study session
  • Participants must be willing not to drive a traffic vehicle or to operate machines for 3h after the sessions
  • Women must have a negative pregnancy test at the beginning of each session.

Exclusion criteria

  • Chronic or acute medical condition.
  • Current or previous personal history of psychotic or major affective disorder.
  • Prior or current alcohol abuse, dangerous drinking behavior (>15 points in the AUDIT questionnaire).
  • Family history of alcoholism (first-degree relative).
  • Alcohol hypersensitivity
  • Prior illicit drug use (except Tetrahydrocannabinol (THC)-containing products) more than 15 times or any time within the previous week.
  • Use of medications that are contraindicated or interfere otherwise with the effects of the study (monoamine oxidase inhibitors, antidepressants, sedatives etc.)
  • Pregnant or nursing women.
  • Participation in another clinical trial (currently or within the last 30 days).

Treatment and study plan

Beer (alcoholic)

Other

Beer (individually calculated amount aiming to achieve a blood-alcohol-centration of 0.4g/kg)

Placebo (non-alcoholic beer)

Other

Non-alcoholic beer serves as Placebo.

Primary outcomes

  1. Effect of beer (alcohol) on emotion recognition

    Time frame: 3 hours

Secondary outcomes

  1. Effect of beer (alcohol) on empathy and social behavior

    Time frame: 3 hours

  2. Subjective effects of beer (alcohol)

    Time frame: 3 hours

  3. Effect of beer (alcohol) on appraisal of visual erotic stimuli

    Time frame: 3 hours

  4. Effects of beer (alcohol) on plasma oxytocin

    Time frame: 3 hours

  5. Effect modulation by genetic polymorphisms

    Time frame: 3 hours

Sponsors and collaborators

Lead sponsor

University Hospital, Basel, Switzerland

Other

Registry information

Important dates

Study start
2014
Primary completion
2015
Study completion
2015
First posted
Dec 17, 2014
Registry last updated
Sep 28, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.